Cargando…

High-Dose Ibuprofen in Cystic Fibrosis

Cystic Fibrosis (CF) is the most common lethal genetic disorder in North America and Europe. Most patients succumb to progressive lung disease characterized by an exaggerated neutrophilic inflammation. In animal models of chronic infection, high-dose ibuprofen was demonstrated to reduce inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lands, Larry C., Dauletbaev, Nurlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036659/ https://www.ncbi.nlm.nih.gov/pubmed/27713350 http://dx.doi.org/10.3390/ph3072213

Ejemplares similares

Rhinovirus Load Is High despite Preserved Interferon-β Response in Cystic Fibrosis Bronchial Epithelial Cells
por: Dauletbaev, Nurlan, et al.
Publicado: (2015)

Infection prevention and control in cystic fibrosis: One size fits all?
por: Lands, Larry C.
Publicado: (2020)

A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis
por: Dauletbaev, N, et al.
Publicado: (2009)

A scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic
por: Dauletbaev, Nurlan, et al.
Publicado: (2022)

High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report
por: Mackey, Jennifer E, et al.
Publicado: (2004)

High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens
por: Muñoz, Adrián J., et al.
Publicado: (2018)

Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens
por: Shah, Parth N., et al.
Publicado: (2018)

Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens
por: Chen, Qingquan, et al.
Publicado: (2023)

Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
por: Ahlgren, Heather G., et al.
Publicado: (2015)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients
por: Wojewodka, Gabriella, et al.
Publicado: (2014)

C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations
por: Matouk, Elias, et al.
Publicado: (2016)

Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF)
por: Hebestreit, Helge, et al.
Publicado: (2021)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers
por: Laine, Loren, et al.
Publicado: (2012)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol
por: Hebestreit, Helge, et al.
Publicado: (2018)

Porosome in Cystic Fibrosis
por: Jena, Bhanu P.
Publicado: (2014)

Nutritional Requirements of Lung Transplant Recipients: Challenges and Considerations
por: Jomphe, Valerie, et al.
Publicado: (2018)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

The role of the UPS in cystic fibrosis
por: Turnbull, Emma L, et al.
Publicado: (2007)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Management of pregnancy in cystic fibrosis
por: Montemayor, Kristina, et al.
Publicado: (2022)

Genome Editing for Cystic Fibrosis
por: Wang, Guoshun
Publicado: (2023)

Gene therapy for the treatment of cystic fibrosis
por: Burney, Tabinda J, et al.
Publicado: (2012)

Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers
por: Dewland, Peter M, et al.
Publicado: (2009)

Aspergillosis and the role of mucins in cystic fibrosis
por: Cowley, Abigail C., et al.
Publicado: (2016)

Bicarbonate Transport in Cystic Fibrosis and Pancreatitis
por: Angyal, Dora, et al.
Publicado: (2021)

Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate
por: Kitak, Teja, et al.
Publicado: (2015)

Clinical Potential of Hyperbaric Pressure-Treated Whey Protein
por: Piccolomini, André F., et al.
Publicado: (2015)

Re-opening the pediatric pulmonary function laboratory during the ongoing COVID-19 pandemic
por: Lands, Larry C.
Publicado: (2022)

High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates
por: Pourarian, Shahnaz, et al.
Publicado: (2015)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
por: Fukuda, Ryosuke, et al.
Publicado: (2020)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
por: Harwood, Kiera H., et al.
Publicado: (2021)

Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review
por: Pinzaru, Anca Daniela, et al.
Publicado: (2023)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
por: Carbone, Annalucia, et al.
Publicado: (2023)

A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass
por: Withington, Davinia E, et al.
Publicado: (2014)

Sinonasal Manifestations in Cystic Fibrosis
por: Oomen, Karin P. Q., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9kahmd1se97dmigrsdrdetd50e